Temporal restriction of MyoD induction and autocatalysis during Xenopus mesoderm formation.
In Xenopus, the activation of the myogenic determination factors MyoD and Myf-5 in the muscle-forming region of the embryo occurs in response to mesoderm-inducing factors (MIFs). Different members of the FGF, TGF-beta, and Wnt protein families have been implicated in this process, but how MIFs induce the myogenic regulators is not known. For MyoD, the induction process may serve to locally stabilize a transient burst of ubiquitous transcription at the midblastula transition, possibly by triggering MyoD's autocatalytic loop. Here we have sought to distinguish separate activating functions during MyoD induction by analyzing when MyoD responds to different MIF signaling or to MyoD autoactivation. We show that MyoD induction depends on the developmental age of the induced cells, rather than on the type or time point of inducer application. At the permissive time, de novo MyoD induction by Activin requires less than 90 min, arguing for an immediate response, rather than a series of inductive events. MyoD autoactivation is direct, but subject to the same temporal restriction as MyoD induction by MIF signaling. Further evidence implicating MyoD autocatalysis as an essential component of the induction process comes from the observation that both autocatalysis and induction of MyoD are selectively repressed by a dominant-negative MyoD mutant. In summary, our observations let us conclude that MyoD's expression domain in the embryo results from an interplay of timed changes in cellular competence, pleiotropic signaling pathways, and autocatalysis.
Friedrich Miescher Laboratorium, Max Planck-Gesellschaft, Spemannstrasse 37-39, Tübingen, 72076, Germany.
O C
OC
Steinbach
A
A
Ulshöfer
A
A
Authaler
R A
RA
Rupp
D028341:Activins; D000818:Animals; D001483:Base Sequence; D017931:DNA Primers / Q000235:genetics; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D006706:Homeostasis; D017403:In Situ Hybridization; D007265:Inhibins / Q000494:pharmacology; D008648:Mesoderm / Q000378:metabolism*; D008954:Models, Biological; D018482:Muscle, Skeletal / Q000196:embryology / Q000378:metabolism; D009154:Mutation; D017570:MyoD Protein / Q000096:biosynthesis* / Q000235:genetics* / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics; D014981:Xenopus / Q000196:embryology* / Q000235:genetics / Q000378:metabolism
D017931:DNA Primers; D017570:MyoD Protein; D012333:RNA, Messenger; D028341:Activins; D007265:Inhibins